Capacity increase of sterile production to 100 million ampoules and vials at Aenova's Gronau site
Aenova starts up the new RABS filling line for ampoules from 1 ml to 5ml.
This is supplemented by fully automatic optical inspection and a new packaging line.
This will enable the Gronau site to produce around 100 million ampoules and vials per year. This corresponds to a capacity increase for sterile liquids of around 7%.
The production and filling of sterile products requires the highest level of safety and quality. Market demand for production capacity in the sterile field has also increased significantly in recent years and has been further boosted by the filling requirements of COVID19 vaccines. At its Gronau site, Aenova, a leading development service provider and contract manufacturer for the pharmaceutical and healthcare industries, has now significantly increased its ampoule capacities. With the new ampoule filling and closing line, the sixth sterile line at the Gronau site, a new fully automatic optical control line and a likewise new packaging line, a total of more than 100 million ampoules and vials can now be produced per year. Aenova's strategy is aimed at significantly expanding capacity and optimizing supply availability at several of the Group's sites.